alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JAN-31-1999
<PERIOD-START>                             FEB-02-1998
<PERIOD-END>                               OCT-31-1998
<CASH>                                          28,875
<SECURITIES>                                         3
<RECEIVABLES>                                   11,584
<ALLOWANCES>                                         0
<INVENTORY>                                    272,343
<CURRENT-ASSETS>                               329,414
<PP&E>                                          69,653
<DEPRECIATION>                                   8,952
<TOTAL-ASSETS>                                 446,475
<CURRENT-LIABILITIES>                          185,541
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           108
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   446,475
<SALES>                                        197,857
<TOTAL-REVENUES>                               222,955
<CGS>                                          138,083
<TOTAL-COSTS>                                   74,476
<OTHER-EXPENSES>                                 5,072
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,418
<INCOME-PRETAX>                                  5,794
<INCOME-TAX>                                     2,397
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,397
<EPS-PRIMARY>                                      .32
<EPS-DILUTED>                                      .30
        

</TABLE>
CERTIFICATIONS

I, Matthew McNeally, Chief Executive Officer of Financial
Ventures, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of
Financial Ventures, Inc.;

2. Based on my knowledge, this quarterly report does not contain
any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not
misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly
present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for,
the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are
responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-14 and 15d-
14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure
that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which
this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure
controls and procedures as of a date within 90 days prior to the
filing date of this quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures based on
our evaluation as of the Evaluation Date;

5. The registrant's other certifying officers and I have
disclosed, based on our most recent evaluation, to the
registrant's auditors and the audit committee of registrant's
board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies in the design or operation of
internal controls which could adversely affect the registrant's
ability to record, process, summarize and report financial data
and have identified for the registrant's auditors any material
weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management
or other employees who have a significant role in the
registrant's internal controls; and

6. The registrant's other certifying officers and I have
indicated in this quarterly report whether there were significant
changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of
our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: August 23, 2007

/s/ Matthew McNeally
-----------------------
Matthew McNeally
Chief Executive Officer


<PAGE>
SCHOOL DISTRICT OF 

HILLSBOROUGH COUNTY 

AND BROADSPIRE,

Appellants,

v.

LORI WATSON, AS LEGAL 

GUARDIAN OF BRENDA 

WHITESIDE,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D15-5231

_____________________________/

Opinion filed July 6, 2016.

An appeal from an order of the Judge of Compensation Claims.

Ellen H. Lorenzen, Judge.

Date of Accident: August 23, 2007.

Katherine Stone of Barbas, Nunez, Sanders, Butler & Hovsepian, Tampa, for 

Appellants.

Nicolette E. Tsambis of Smith, Feddeler & Smith, P.A., Lakeland, for Appellee.

PER CURIAM.

AFFIRMED.

LEWIS, WETHERELL, and RAY, JJ., CONCUR.
#### Patricia Gifford v. The Soma Group, Inc. et al.

Superior Court, Worcester, SS

No.200002375

Memorandum Dated November 3, 2004

*467Agnes, A. J.

1. This is a civil action that was tried to a juiy on August 23, 2004 on the basis of a complaint alleging unlawful sex-based discrimination and unlawful handicapped-based discrimination in violation of G.L.c. 15 IB, and a wage claim under G.L.c. 149, § 150. The handicap discrimination claim was resolved in the defendant’s favor at the close of the plaintiffs case. On August 26, 2004, the jury returned a verdict in favor of the defendant on the sex discrimination claim and awarded the plaintiff $3,640 on the wage claim (count six).

2. For the reasons set forth in the plaintiffs Memorandum of Law at 2, earned vacation time is treated as wages under G.L.c. 149, §148.

3. With regard to the issue of whether an award of damages representing unpaid wages must be trebled by the terms of G.L.c. 149, §150 (authorizing an employee to file suit for a violation of G.L.c. 149, §148 and stating that “any damages incurred, including treble damages for any loss of wages and other benefits ...”), I follow the reasoning of this court in *Parrow v. Howard,*Middlesex Superior Court No. 02-1403, 17 Mass. L. Rptr. 149 (11/12/2003) (Graham, J.). In *Parrow,*the court observed that

> whether such an award is mandatory or discretionary need not be addressed here. That issue is irrelevant because this court concludes that, even if discretionary, treble damages are warranted. Although the actions of the defendants cannot be described as outrageous and stemming from an evil motive, their actions were willfully indifferent to the Plaintiffs’ rights.

*Id.*at 3. Accordingly, the judgment on count six in this case should be $10,920.00

4. With regard to the matter of attorneys fees, §150 also provides for an award of “reasonable attorneys fees.” The law is settled that the attorneys fees awarded in such circumstances need not be a fraction of the damage award and may exceed the damage award. The plaintiff has attached to her Memorandum of Law a comprehensive record of the time spent by trial counsel in prosecuting this case to a conclusion over a period of four years. Plaintiff estimates that 25% of those expenditures should be assigned to the wage claim. Plaintiffs Memorandum of Law at 6. Defendants counter that considering the factors identified as relevant when calculating fees under the Lodestar Theoiy, *see Fontaine v. Ebtech Corp.,*415 Mass. 309 (1993), such as length of the trial, difficulty of the legal and factual issues, degree of competence of counsel, nature of the case, time and labor required and results obtained that the award should be approximately 1/3 of the damage award. Based on my knowledge of the case and the skillful representation provided by plaintiffs counsel, I believe an appropriate and fair award of attorneys fees in connection with the successful wage claim under G.L.c. 149, §150 is 10% or $15,925. Accordingly, the judgment on count six should include an award of attorneys fees in the amount of $15,925.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A)
CONSOLIDATED BALANCE SHEET & STATEMENT OF OPERATIONS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH (B) FORM 10-K - COMMUNICATIONS & POWER INDUSTRIES
HOLDING CORPORATION FOR YEAR ENDED SEPTEMBER 27, 1996.
</LEGEND>
<CIK> 0001000654
<NAME> COMMUNICATIONS & POWER INDUSTRIES HOLDING CORPORATION
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-27-1996
<PERIOD-START>                             SEP-30-1995
<PERIOD-END>                               SEP-27-1996
<CASH>                                           1,753
<SECURITIES>                                         0
<RECEIVABLES>                                   50,380
<ALLOWANCES>                                         0
<INVENTORY>                                     46,471
<CURRENT-ASSETS>                               107,846
<PP&E>                                          79,873
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 228,142
<CURRENT-LIABILITIES>                           73,270
<BONDS>                                        135,650
<PREFERRED-MANDATORY>                           14,822
<PREFERRED>                                          0
<COMMON>                                             2
<OTHER-SE>                                     (6,381)
<TOTAL-LIABILITY-AND-EQUITY>                   228,142
<SALES>                                        257,449
<TOTAL-REVENUES>                               257,449
<CGS>                                          184,482
<TOTAL-COSTS>                                  184,482
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,894
<INCOME-PRETAX>                                 10,411
<INCOME-TAX>                                     2,068
<INCOME-CONTINUING>                              8,343
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     8,343
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
# Official Journal L 121/2019

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 121 |
| | |
| English edition | Legislation | Volume 628 May 2019 |

ISSN 1977-0677

Official Journal

of the European Union

L 121

English edition

Legislation

Volume 628 May 2019

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | DECISIONS |
| | * | Commission Decision (EU) 2019/701 of 5 April 2019 establishing a glossary of common ingredient names for use in the labelling of cosmetic products (
  1
  ) | 1 |

Contents

II   Non-legislative acts

page

DECISIONS

*

Commission Decision (EU) 2019/701 of 5 April 2019 establishing a glossary of common ingredient names for use in the labelling of cosmetic products (
  1
  )

1

1

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
#### LUZERNE CHEMICAL CO., Appellant, v. KENNEY et al., Respondents.

(Supreme Court, Appellate Division, Third Department.

November 20, 1907.)

Action by the Luzerne Chemical Company against Edward Kenney and others.

PER CURIAM.

Judgment affirmed, with

KELLOGG, J., dissents. COCHRANE, J., not sitting.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the Globecomm
Systems Inc. Consolidated Financial Statements, and is qualified in its
entirety by reference to such consolidated financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               SEP-30-1999
<CASH>                                          15,088
<SECURITIES>                                         0
<RECEIVABLES>                                   24,598
<ALLOWANCES>                                        52
<INVENTORY>                                      5,237
<CURRENT-ASSETS>                                46,642
<PP&E>                                          26,484
<DEPRECIATION>                                   2,797
<TOTAL-ASSETS>                                  74,497
<CURRENT-LIABILITIES>                           18,815
<BONDS>                                              0
<PREFERRED-MANDATORY>                            5,000
<PREFERRED>                                          0
<COMMON>                                             9
<OTHER-SE>                                      38,292
<TOTAL-LIABILITY-AND-EQUITY>                    74,497
<SALES>                                         19,425
<TOTAL-REVENUES>                                19,425
<CGS>                                           16,917
<TOTAL-COSTS>                                    3,435
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                    52
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  (739)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (739)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (739)
<EPS-BASIC>                                     (0.08)
<EPS-DILUTED>                                   (0.08)




</TABLE>
III 

112TH CONGRESS 

1ST SESSION S. RES. 215 

Designating the month of June 2011 as ‘‘National Cytomegalovirus Awareness 

Month’’. 

IN THE SENATE OF THE UNITED STATES 

JUNE 23, 2011 

Ms. MIKULSKI (for herself and Ms. MURKOWSKI) submitted the following 

resolution; which was considered and agreed to 

RESOLUTION 

Designating the month of June 2011 as ‘‘National 

Cytomegalovirus Awareness Month’’. 

Whereas congenital Cytomegalovirus (referred to in this preamble as ‘‘CMV’’) is the most common congenital infection in the United States with 1 in 150 children born 

with congenital CMV; 

Whereas congenital CMV is the most common cause of birth 

defects and childhood disabilities in the United States; 

Whereas congenital CMV is preventable with behavioral interventions such as practicing frequent hand washing with 

soap and water after contact with diapers or oral secretions, not kissing young children on the mouth, and not 

sharing food, towels, or utensils with young children; 


jlentini on DSK4TPTVN1PROD with BILLS
2 

•SRES 215 ATS 

Whereas CMV is found in bodily fluids, including urine, saliva, blood, mucus, and tears; 

Whereas congenital CMV can be diagnosed if the virus is 

found in urine, saliva, blood, or other body tissues of an 

infant during the first week after birth; 

Whereas CMV infection is more common than the combined 

metabolic or endocrine disorders currently in the United 

States core newborn screening panel; 

Whereas most people are not aware of their CMV infection 

status, with pregnant women being 1 of the highest risk 

groups; 

Whereas the American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention recommend that OB/GYNs counsel women on 

basic prevention measures to guard against CMV infection; 

Whereas in 1999, the Institute of Medicine stated that development of a CMV vaccine was the highest priority for 

new vaccines; 

Whereas the incidence of children born with congenital CMV 

can be greatly reduced with public education and awareness; and 

Whereas a comprehensive understanding of CMV provides opportunities to improve the health and well-being of our 

children: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates the month of June 2011 as ‘‘Na3 tional Cytomegalovirus Awareness Month’’ in order 

4 to raise awareness of the dangers of 


jlentini on DSK4TPTVN1PROD with BILLS
3 

•SRES 215 ATS 

1 Cytomegalovirus (‘‘CMV’’) and reduce the occur2 rence of congenital CMV infection; and 

3 (2) recommends that more effort be taken to 

4 counsel women of childbearing age of the effect this 

5 virus can have on their children. 

Æ 


jlentini on DSK4TPTVN1PROD with BILLS
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001031425
<NAME>                        East Coast Beverage Corp.
<MULTIPLIER>                                   1
<CURRENCY>                                     US

<S>                             <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-1-2000
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  3,173,819
<ALLOWANCES>                                   0
<INVENTORY>                                    1,489,674
<CURRENT-ASSETS>                               4,826,647
<PP&E>                                         975,340
<DEPRECIATION>                                 228,320
<TOTAL-ASSETS>                                 5,573,667
<CURRENT-LIABILITIES>                          4,723,107
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       897
<OTHER-SE>                                     849,663
<TOTAL-LIABILITY-AND-EQUITY>                   5,573,667
<SALES>                                        5,551,267
<TOTAL-REVENUES>                               5,551,267
<CGS>                                          3,841,655
<TOTAL-COSTS>                                  4,960,606
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             63,470
<INCOME-PRETAX>                                (3,314,464)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (3,314,464)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (3,314,464)
<EPS-BASIC>                                    (0.44)
<EPS-DILUTED>                                  (0.44)





</TABLE>
EXHIBIT 31.1



CERTIFICATION



I, Jack Gregory, certify that:



(1)I have reviewed this quarterly report on Form 10-Q of Premier Holding Corp.;





(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;





(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;





(4) The small business issuers other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:





(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;





(c) Evaluated the effectiveness of the small business issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and





(d) Disclosed in this report any change in the small business issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter (the small business issuers fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting; and





(5) The small business issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of the small business issuers board of directors (or persons performing the equivalent functions):





(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and





(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers internal control over financial reporting.



|Date:  March 25, 2010 | Jack Gregory
Chief Executive Officer and Director
|--------------------- | -------------------------------------------------